HomeCompareTRUMF vs EPRT

TRUMF vs EPRT: Dividend Comparison 2026

TRUMF yields 1.42% · EPRT yields 3.97%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 TRUMF wins by $551.9K in total portfolio value· pulled ahead in Year 5
10 years
TRUMF
TRUMF
● Live price
1.42%
Share price
$12.38
Annual div
$0.18
5Y div CAGR
75.5%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$616.2K
Annual income
$410,809.26
Full TRUMF calculator →
EPRT
EPRT
● Live price
3.97%
Share price
$30.36
Annual div
$1.21
5Y div CAGR
29%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$64.3K
Annual income
$13,170.85
Full EPRT calculator →

Portfolio growth — TRUMF vs EPRT

📍 TRUMF pulled ahead of the other in Year 5

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodTRUMFEPRT
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, TRUMF + EPRT cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
TRUMF pays
EPRT pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

TRUMF
Annual income on $10K today (after 15% tax)
$120.65/yr
After 10yr DRIP, annual income (after tax)
$349,187.87/yr
EPRT
Annual income on $10K today (after 15% tax)
$337.37/yr
After 10yr DRIP, annual income (after tax)
$11,195.22/yr
At 15% tax rate, TRUMF beats the other by $337,992.65/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of TRUMF + EPRT for your $10,000?

TRUMF: 50%EPRT: 50%
100% EPRT50/50100% TRUMF
Portfolio after 10yr
$340.3K
Annual income
$211,990.06/yr
Blended yield
62.30%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on EPRT right now

TRUMF
No analyst data
Altman Z
4.0
Piotroski
7/9
EPRT
Analyst Ratings
1
Strong
17
Buy
3
Hold
1
Sell
Consensus: Buy
Price Target
$35.50
+16.9% upside vs current
Range: $33.00 — $37.00
Altman Z
1.8
Piotroski
5/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

TRUMF buys
0
EPRT buys
0
No recent congressional trades found for TRUMF or EPRT in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricTRUMFEPRT
Forward yield1.42%3.97%
Annual dividend / share$0.18$1.21
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR75.5%29%
Portfolio after 10y$616.2K$64.3K
Annual income after 10y$410,809.26$13,170.85
Total dividends collected$576.3K$38.7K
Payment frequencyquarterlyquarterly
SectorStockREIT

Year-by-year: TRUMF vs EPRT ($10,000, DRIP)

YearTRUMF PortfolioTRUMF Income/yrEPRT PortfolioEPRT Income/yrGap
1$10,949$249.12$11,212$512.01$263.00EPRT
2$12,163$447.38$12,689$692.09$526.00EPRT
3$13,829$815.13$14,521$944.30$692.00EPRT
4$16,318$1,520.16$16,841$1,302.88$523.00EPRT
5← crossover$20,402$2,941.94$19,841$1,821.64+$561.00TRUMF
6$27,863$6,033.08$23,818$2,587.47+$4.0KTRUMF
7$43,328$13,514.24$29,230$3,744.65+$14.1KTRUMF
8$80,829$34,468.45$36,816$5,540.38+$44.0KTRUMF
9$191,954$105,467.10$47,806$8,413.17+$144.1KTRUMF
10$616,200$410,809.26$64,324$13,170.85+$551.9KTRUMF

TRUMF vs EPRT: Complete Analysis 2026

TRUMFStock

Terumo Corporation engages in the manufacture and sale of medical products and equipment worldwide. The company operates through three segments: Cardiac and Vascular Company, Medical Care Solutions Company, and Blood and Cell Technologies Company. The Cardiac and Vascular Company segment offers angiographic guidewires, angiographic catheters, introducer sheaths, vascular closure devices, PTCA balloon catheters, coronary stents, self-expanding peripheral stents, intravascular ultrasound systems, imaging catheters, and others; coils, stents, and intrasaccular devices for treating cerebral aneurysm; embolization systems, aspiration catheters, and clot retrievers for treating ischemic stroke and others; oxygenators, cardio-pulmonary bypass systems, and others; and artificial vascular and stent grafts. The Medical Care Solutions Company segment provides syringes, infusion pumps, syringe pumps, infusion lines, I.V. solutions, peritoneal dialysis fluids, pain management and nutritious food products, adhesion barriers, and others; blood glucose monitoring systems, disposable needles for pen-injector, insulin patch pumps, blood pressure monitors, digital thermometers, and others; and contract manufacturing of prefilled syringes, devices to pharmaceutical companies for use in drug kits, such as prefillable syringes, needles for pharmaceutical packaging business, and others. The Blood and Cell Technologies Company segment offers blood bags, component collection systems, automated blood processing systems, pathogen reduction systems, centrifugal apheresis systems, cell expansion systems, and others. The company was formerly known as Sekisen Ken-onki Corporation and changed its name to Terumo Corporation in October 1974. Terumo Corporation was incorporated in 1921 and is headquartered in Tokyo, Japan.

Full TRUMF Calculator →

EPRTREIT

Essential Properties Realty Trust, Inc., a real estate company, acquires, owns, and manages single-tenant properties in the United States. The company leases its properties to middle-market companies, such as restaurants, car washes, automotive services, medical and dental services, convenience stores, equipment rental, entertainment, early childhood education, grocery, and health and fitness on a long-term basis. As of December 31, 2021, it had a portfolio of 1, 451 properties. The company qualifies as a real estate investment trust for federal income tax purposes. It generally would not be subject to federal corporate income taxes if it distributes at least 90% of its taxable income to its stockholders. The company was founded in 2016 and is headquartered in Princeton, New Jersey.

Full EPRT Calculator →
📬

Get this TRUMF vs EPRT comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

TRUMF vs SCHDTRUMF vs JEPITRUMF vs OTRUMF vs KOTRUMF vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.